NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Molecular Templates Inc (NASDAQ: MTEM)

 
MTEM Technical Analysis
5
As on 9th Jun 2023 MTEM STOCK Price closed @ 0.47 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.66 & Strong Sell for SHORT-TERM with Stoploss of 3.15 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MTEMSTOCK Price

Open 0.47 Change Price %
High 0.50 1 Day -0.01 -2.08
Low 0.47 1 Week 0.00 0.00
Close 0.47 1 Month 0.08 20.51
Volume 30119 1 Year -3.20 -87.19
52 Week High 4.15 | 52 Week Low 0.33
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
MTEM
Daily Charts
MTEM
Intraday Charts
Whats New @
Bazaartrend
MTEM
Free Analysis
 
MTEM Important Levels Intraday
RESISTANCE0.53
RESISTANCE0.51
RESISTANCE0.50
RESISTANCE0.49
SUPPORT0.45
SUPPORT0.44
SUPPORT0.43
SUPPORT0.41
 
MTEM Forecast May 2024
4th UP Forecast3.63
3rd UP Forecast2.62
2nd UP Forecast1.99
1st UP Forecast1.36
1st DOWN Forecast-0.42
2nd DOWN Forecast-1.05
3rd DOWN Forecast-1.68
4th DOWN Forecast-2.69
 
MTEM Weekly Forecast
4th UP Forecast2.69
3rd UP Forecast1.98
2nd UP Forecast1.54
1st UP Forecast1.10
1st DOWN Forecast-0.16
2nd DOWN Forecast-0.60
3rd DOWN Forecast-1.04
4th DOWN Forecast-1.75
 
MTEM Forecast2024
4th UP Forecast8.45
3rd UP Forecast5.89
2nd UP Forecast4.31
1st UP Forecast2.73
1st DOWN Forecast-1.79
2nd DOWN Forecast-3.37
3rd DOWN Forecast-4.95
4th DOWN Forecast-7.51
 
 
MTEM Other Details
Segment EQ
Market Capital 296993280.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MTEM Address
MTEM
 
MTEM Latest News
 
Your Comments and Response on Molecular Templates Inc
 
MTEM Business Profile
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. Its proprietary drug platform technology is engineered toxin bodies (ETBs). The company's lead drug candidate is MT-3724 that is in a Phase II clinical trial for the treatment of relapsed and refractory diffuse large B-cell lymphoma; and Phase II clinical trial for treating non-Hodgkin's lymphoma. It also develops MT-4019, engineered toxin body targeting CD38; TAK-169 targeting CD38 is in Phase I clinical trial; MT-5111 targeting HER2 is in Phase I clinical trial; and MT-6402 with antigen seeding targeting PD-L1. The company has an agreement with Takeda Pharmaceutical Company Limited to develop CD38-targeted engineered toxin bodies for the treatment of patients with diseases, such as multiple myeloma; and a strategic research collaboration with Vertex Pharmaceuticals Incorporated to discover and develop novel targeted biologic therapies for applications outside of oncology; and Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. is headquartered in Austin, Texas. Address: 9301 Amberglen Boulevard, Austin, TX, United States, 78729
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service